CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: A meta-analysis

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 11, 2015, Pages 14685-14692

  Guo, Yang ^a   Zhou, Shan ^a   Liu, Feng ^b   Zhang, Bin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Department of Adolescent Medicine Harbin Children s Hospital   (China)

Author keywords

CYP2E1; Meta analysis; Oral cancer; Polymorphism

Indexed keywords

CYTOCHROME P450 2E1;

GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HUMAN; META ANALYSIS; MOUTH TUMOR; ODDS RATIO;

CYTOCHROME P-450 CYP2E1; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MOUTH NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC;

EID: 85013345392     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol 2009; 45: 309-316.
2. Marichalar-Mendia X, Rodriguez-Tojo MJ, Acha-Sagredo A, Rey-Barja N and Aguirre-Urizar JM. Oral cancer and polymorphism of ethanol metabolising genes. Oral Oncol 2010; 46: 9-13.
3. Peters ES, McClean MD, Liu M, Eisen EA, Mueller N and Kelsey KT. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use. Cancer Epidemiol Biomarkers Prev 2005; 14: 476-482.
4. Gattas GJ, de Carvalho MB, Siraque MS, Curioni OA, Kohler P, Eluf-Neto J and Wunsch-Filho V. Genetic polymorphisms of CYP1A1, CYP2E1, GSTM1, and GSTT1 associated with head and neck cancer. Head Neck 2006; 28: 819-826.
5. Hashibe M, Brennan P, Benhamou S, Castellsague X, Chen C, Curado MP, Dal Maso L, Daudt AW, Fabianova E, Fernandez L, Wunsch-Filho V, Franceschi S, Hayes RB, Herrero R, Koifman S, La Vecchia C, Lazarus P, Levi F, Mates D, Matos E, Menezes A, Muscat J, Eluf-Neto J, Olshan AF, Rudnai P, Schwartz SM, Smith E, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Wei Q, Winn DM, Zaridze D, Zatonski W, Zhang ZF, Berthiller J and Boffetta P. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J Natl Cancer Inst 2007; 99: 777-789.
6. Ho T, Wei Q and Sturgis EM. Epidemiology of carcinogen metabolism genes and risk of squamous cell carcinoma of the head and neck. Head Neck 2007; 29: 682-699.
7. Hayashi S, Watanabe J and Kawajiri K. Genetic polymorphisms in the 5'-flanking region change transcriptional regulation of the human cytochrome P450IIE1 gene. J Biochem 1991; 110: 559-565.
8. Liu S, Park JY, Schantz SP, Stern JC and Lazarus P. Elucidation of CYP2E1 5' regulatory RsaI/Pstl allelic variants and their role in risk for oral cancer. Oral Oncol 2001; 37: 437-45.
9. Lieber CS. Cytochrome P-4502E1: its physiological and pathological role. Physiol Rev 1997; 77: 517-544.
10. Watanabe J, Hayashi S and Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flanking region. J Biochem 1994; 116: 321-326.
11. Hung HC, Chuang J, Chien YC, Chern HD, Chiang CP, Kuo YS, Hildesheim A and Chen CJ. Genetic polymorphisms of CYP2E1, GSTM1, and GSTT1; environmental factors and risk of oral cancer. Cancer Epidemiol Biomarkers Prev 1997; 6: 901-905.
12. Lau J, Ioannidis JP and Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997; 127: 820-826.
13. Mantel N and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-748.
14. DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-188.
15. Munafo MR, Clark TG and Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 2004; 129: 39-44.
16. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
17. Balaji L, Singh KB and Bhaskar LV. Genetic Polymorphisms of the CYP2E1 Gene do not Contribute to Oral Cancer Susceptibility in South Indians. Asian Pac J Cancer Prev 2011; 12: 1523-1527.
18. Brocic M, Supic G, Zeljic K, Jovic N, Kozomara R, Zagorac S, Zlatkovic M and Magic Z. Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma. Otolaryngol Head Neck Surg 2011; 145: 586-593.
19. Sugimura T, Kumimoto H, Tohnai I, Fukui T, Matsuo K, Tsurusako S, Mitsudo K, Ueda M, Tajima K and Ishizaki K. Gene-environment interaction involved in oral carcinogenesis: molecular epidemiological study for metabolic and DNA repair gene polymorphisms. J Oral Pathol Med 2006; 35: 11-18.
20. Zavras AI, Wu T, Laskaris G, Wang YF, Cartsos V, Segas J, Lefantzis D, Joshipura K, Douglass CW and Diehl SR. Interaction between a single nucleotide polymorphism in the alcohol dehydrogenase 3 gene, alcohol consumption and oral cancer risk. Int J Cancer 2002; 97: 526-530.
21. Bouchardy C, Hirvonen A, Coutelle C, Ward PJ, Dayer P and Benhamou S. Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 2000; 87: 734-740.
22. Morita S, Yano M, Tsujinaka T, Akiyama Y, Taniguchi M, Kaneko K, Miki H, Fujii T, Yoshino K, Kusuoka H and Monden M. Genetic polymorphisms of drug-metabolizing enzymes and susceptibility to head-and-neck squamous-cell carcinoma. Int J Cancer 1999; 80: 685-688.
23. Katoh T, Kaneko S, Kohshi K, Munaka M, Kitagawa K, Kunugita N, Ikemura K and Kawamoto T. Genetic polymorphisms of tobaccoand alcohol-related metabolizing enzymes and oral cavity cancer. Int J Cancer 1999; 83: 606-609.
24. Soya SS, Vinod T, Reddy KS, Gopalakrishnan S and Adithan C. CYP2E1 polymorphisms and gene-environment interactions in the risk of upper aerodigestive tract cancers among Indians. Pharmacogenomics 2008; 9: 551-560.
25. Marques CF, Koifman S, Koifman RJ, Boffetta P, Brennan P and Hatagima A. Influence of CYP1A1, CYP2E1, GSTM3 and NAT2 genetic polymorphisms in oral cancer susceptibility: results from a case-control study in Rio de Janeiro. Oral Oncol 2006; 42: 632-637.
26. Anantharaman D, Samant TA, Sen S and Mahimkar MB. Polymorphisms in tobacco metabolism and DNA repair genes modulate oral precancer and cancer risk. Oral Oncol 2011; 47: 866-872.
27. Buch SC, Nazar-Stewart V, Weissfeld JL and Romkes M. Case-control study of oral and oropharyngeal cancer in whites and genetic variation in eight metabolic enzymes. Head Neck 2008; 30: 1139-1147.
28. Hakenewerth AM, Millikan RC, Rusyn I, Herring AH, North KE, Barnholtz-Sloan JS, Funkhouser WF, Weissler MC and Olshan AF. Joint effects of alcohol consumption and polymorphisms in alcohol and oxidative stress metabolism genes on risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev 2011; 20: 2438-2449.
29. Lu D, Yu X and Du Y. Meta-analyses of the effect of cytochrome P450 2E1 gene polymorphism on the risk of head and neck cancer. Mol Biol Rep 2011; 38: 2409-2416.
30. Rau D, Koster A, Tittelbach H, Sachse R, Landgraf S, Neubauer S, Giedl J, Dingermann T and Gebhart E. Chromosome and oncogene studies in human rectal and colon carcinomas. Anticancer Res 1991; 11: 1477-1484.
31. Couturier-Turpin MH, Couturier D, Nepveux P, Louvel A, Chapuis Y and Guerre J. Human chromosome analysis in 24 cases of primary carcinoma of the large intestine: contribution of the G-banding technique. Br J Cancer 1982; 46: 856-869.
32. Tang K, Li Y, Zhang Z, Gu Y, Xiong Y, Feng G, He L and Qin S. The PstI/RsaI and DraI polymorphisms of CYP2E1 and head and neck cancer risk: a meta-analysis based on 21 case-control studies. BMC Cancer 2010; 10: 575.
33. Hirschhorn JN, Lohmueller K, Byrne E and Hirschhorn K. A comprehensive review of genetic association studies. Genet Med 2002; 4: 45-61.